Physician

Allen M Segal, D.O.

According to 2025 Medicare claims, Allen Segal, D.O. (NPI: 1497730220) practices rheumatology in the Cleveland, OH market, with the plurality of this provider's patient population coming from Cuyahoga, OH. This provider's primary affiliated billing organization is UNIVERSITY PRIMARY CARE PRACTICES INC (NPI: 1720220098; TIN: 341768928) and primary practice location at 44121-4129. Segal is affiliated with the University Hospitals Coordinated Care Organization (ACO ID: A1262) and Vytalize Health 9 ACO LLC (ACO ID: D0313), participating under both the MSSP and REACH models.

Segal's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 261 traditional Medicare patients, billed 2,063 HCPCS/CPT codes, and received $41,079 in Medicare payments. The top billing code was 99205 (New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more). Part D data shows 2,043 prescription claims across 316 beneficiaries totaling $1,597,375 in drug costs, led by Enbrel Mini (Etanercept). Open Payments data shows 43 records totaling $991. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $138,089 to $1,597,375. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	127	1,033	$32,392
2016	224	1,364	$46,187
2017	232	2,374	$65,280
2018	248	4,135	$95,013
2019	273	4,932	$105,197
2020	205	2,223	$54,407
2021	193	462	$35,401
2022	242	625	$42,476
2023	237	594	$39,373
2024	261	2,063	$41,079

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	118	645	$138,089
2016	210	1,281	$406,372
2017	237	1,844	$766,819
2018	268	2,135	$794,984
2019	280	2,108	$1,038,525
2020	273	2,104	$854,511
2021	256	1,889	$892,596
2022	259	1,876	$1,151,487
2023	313	2,159	$1,849,003
2024	316	2,043	$1,597,375

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99205	New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more	24	24	$143
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	68	68	$114
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	148	235	$80
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	45	59	$62
J3301	Injection, triamcinolone acetonide, not otherwise specified, 10 mg	22	155	$1

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Enbrel Mini	Etanercept	39	1,092	$278,606
Enbrel Sureclick	Etanercept	34	952	$265,560
Orencia Clickject	Abatacept	27	812	$162,109
Xeljanz Xr	Tofacitinib Citrate	16	906	$153,902
Humira Pen	Adalimumab	17	504	$124,483

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	43	$991	Amgen Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Allen M. Segal, D.O.?

Tedicare shows public-source Medicare data for Allen M. Segal, D.O. (NPI 1497730220), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Allen M. Segal, D.O. have ACO affiliation data?

Allen M. Segal, D.O. is shown with ACO affiliation data for University Hospitals Coordinated Care Organization (MSSP, ACO ID A1262) and Vytalize Health 9 ACO LLC (REACH, ACO ID D0313).

What billing organization is linked to Allen M. Segal, D.O.?

Allen M. Segal, D.O. is linked to UNIVERSITY PRIMARY CARE PRACTICES INC (billing NPI 1720220098) in the available physician profile data.

Does Allen M. Segal, D.O. have Open Payments data?

Allen M. Segal, D.O. has 43 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.